Core Viewpoint - The company has completed the investment projects funded by the 2019 private placement of shares and plans to permanently supplement its working capital with the remaining funds, which aligns with regulatory requirements and benefits the company and its shareholders [1][5][6]. Fundraising Overview - The company raised a total of approximately RMB 500 million through the issuance of 79,239,302 shares at RMB 6.31 per share, with net proceeds amounting to approximately RMB 486.57 million after deducting issuance costs [1][2]. - The funds were allocated to three main projects, with a total intended investment of RMB 486.57 million [2]. Fund Usage and Surplus - As of August 25, 2025, the total investment in the projects was approximately RMB 440.51 million, resulting in a surplus of RMB 47.14 million [3]. - The surplus funds will be used to permanently supplement the company's working capital, which is essential for daily operations [4]. Reasons for Surplus - The surplus was achieved through effective cost control and management during the project execution, ensuring quality while minimizing expenses [4]. Impact of Fund Allocation - The decision to permanently supplement working capital with the surplus funds is expected to enhance the efficiency of fund usage and alleviate financial pressure on the company, benefiting overall operations [4][6]. Review Procedures - The board of directors and the supervisory board approved the proposal regarding the completion of the fundraising projects and the allocation of surplus funds on August 25, 2025, without the need for a shareholder meeting [5]. - The sponsor institution confirmed that the actions taken are in compliance with relevant regulations and do not harm the interests of shareholders [6].

Core Viewpoint - The company has completed the fundraising project from its 2019 private placement and plans to permanently supplement its working capital with the remaining funds of 47.1431 million yuan [1][2][5]. Fundraising Project Summary - The company raised a total of approximately 500 million yuan through the issuance of 79,239,302 shares at a price of 6.31 yuan per share, with net proceeds after fees amounting to approximately 486.57 million yuan [2][3]. - The funds were allocated to three projects, with a total planned investment of 48.65679 million yuan [3]. Fund Usage and Surplus - As of August 25, 2025, the total amount invested in the projects was approximately 44.05089 million yuan, leaving a surplus of 4.71431 million yuan [4]. - The surplus funds will be used to permanently supplement the company's working capital, which is essential for daily operations [4][5]. Reasons for Surplus - The surplus was primarily due to effective cost control and management during the project execution, ensuring quality while minimizing expenses [4]. Approval Process - The proposal to conclude the fundraising project and allocate the surplus funds was approved by the company's board and supervisory committee on August 25, 2025, without the need for a shareholder meeting [6][7]. - The sponsor institution confirmed that the decision complies with relevant regulations and does not harm the interests of shareholders [7].

Fundraising Overview - The company raised a total of RMB 500 million through a non-public offering of 79,239,302 shares at RMB 6.31 per share, with a net amount of RMB 486.68 million after deducting underwriting fees and other expenses [1][2] - The funds were deposited into a special account managed by the underwriter, Dongfang Securities [1] Fund Utilization and Balance - As of the reporting date, the net amount of funds utilized was RMB 429.95 million, with an interest income of RMB 0.96 million, resulting in a remaining balance of RMB 47.70 million [2][4] - The company has not encountered any abnormal situations regarding the investment projects funded by the raised capital [4] Fund Management Practices - The company has established a management system for the raised funds, including special account storage and regulatory agreements with banks to ensure proper usage [3][4] - The company has signed four-party and three-party regulatory agreements with banks to clarify the rights and obligations of all parties involved [3] Project Status and Adjustments - The company has extended the timeline for the expected usability of certain projects, including the "Core Component Production Base for Aircraft Seats" and "Seat R&D Center," from December 2024 to December 2025 due to market demand recovery issues [5][6] - There have been no changes in the investment projects funded by the raised capital, and the company has adhered to the original investment plans [4][5]